Venture Capital
Boston, Massachusetts, 02199
Creating and investing in life sciences companies that target our world's most urgent medical needs. We chose the last letter of the Greek alphabet Ω as our brand because we start our investment process by focusing on the end goal - delivering impactful medicines to patients. We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others. We are guided by our conviction in people, products and breakthrough ideas, not by conventional categories... Our investments span a variety of instruments from early venture rounds, to late-stage investing, direct secondary transactions, as well as company founding and creation.
122023sbs
